Michael Sarcone
Stock Analyst at Jefferies
(n/a)
# 4,832
Out of 4,918 analysts
6
Total ratings
n/a
Success rate
-36.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $1.30 | +53.44% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $49.96 | +90.15% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $86.16 | +45.08% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $5.50 | +81.82% | 1 | Mar 21, 2023 | |
| AXGN Axogen | Assumes: Buy | $15 | $12.67 | +18.39% | 1 | Nov 11, 2022 |
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $1.30
Upside: +53.44%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $49.96
Upside: +90.15%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $86.16
Upside: +45.08%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $5.50
Upside: +81.82%
Axogen
Nov 11, 2022
Assumes: Buy
Price Target: $15
Current: $12.67
Upside: +18.39%